Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its availability is overseen by Health https://vyvansepharmacyincanada906173.blogitright.com/43162863/lisdexamfetamine-in-canada-a-complete-guide